BioLight Life Sciences Ltd. (TLV:BOLT)
Israel · Delayed Price · Currency is ILS · Price in ILA 370.60
+23.00 (6.62%)
Aug 3, 2026, 5:24 PM IDT
BioLight Life Sciences Market Cap
BioLight Life Sciences has a market cap or net worth of 31.56 million as of August 3, 2026. Its market cap has increased by 24.47% in one year.
Market Cap
31.56M
Enterprise Value
14.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
370.60
ChartMarket Cap Chart
Since January 11, 2006, BioLight Life Sciences's market cap has decreased from 47.74M to 31.56M, a decrease of -33.90%. That is a compound annual growth rate of -1.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 33.65M | 5.71% |
| Dec 31, 2025 | 31.83M | 25.69% |
| Dec 31, 2024 | 25.32M | 4.99% |
| Dec 31, 2023 | 24.12M | -19.99% |
| Dec 29, 2022 | 30.15M | -42.70% |
| Dec 30, 2021 | 52.62M | 53.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geffen Residence & Renewal | 322.94M |
| Bonus BioGroup | 309.56M |
| Matricelf | 72.59M |
| BioLineRx | 41.94M |
| Clal Biotechnology Industries | 40.47M |
| Can-Fite BioPharma | 22.11M |
| XTL Biopharmaceuticals | 19.66M |
| Purple Biotech | 18.65M |